Related Experiment Videos
G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population
W Pickering1, K Marriott, L Regan
1Department of Haematology, Imperial College School of Medicine, St Mary's Hospital, London, United Kingdom.
Summary
The G20210A prothrombin gene mutation was not more common in women with recurrent pregnancy loss. This thrombophilia may still be relevant in specific subgroups with early losses and other clotting defects.
Area of Science:
- Reproductive Medicine
- Genetics
- Thrombophilia
Background:
- Recurrent pregnancy loss (RPL) is a significant concern, with thrombotic causes suspected in many cases.
- The G20210A prothrombin gene mutation is a known thrombophilia that may contribute to pregnancy complications.
Purpose of the Study:
- To investigate the prevalence of the G20210A prothrombin gene mutation in women with a history of recurrent pregnancy loss.
- To compare mutation prevalence between patients and a control group of healthy parous women.
Main Methods:
- Case-control study involving 122 women with recurrent pregnancy loss (early, late, or mixed) and 66 healthy controls.
- Genotyping for the G20210A prothrombin gene mutation was performed.
- Statistical analysis included odds ratios and confidence intervals.
Main Results:
- The prevalence of the G20210A mutation was 3.3% in patients and 4.5% in controls (p=0.32).
- No statistically significant difference in mutation prevalence was observed between groups, even when analyzing Caucasian subgroups.
- The mutation was only detected in patients experiencing early pregnancy losses.
Conclusions:
- The G20210A prothrombin gene mutation is not a common risk factor for recurrent pregnancy loss overall.
- The mutation's potential role in specific subgroups, such as those with early losses or additional thrombophilic defects, warrants further investigation.